• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Natera, Inc. - Common Stock (NQ:NTRA)

212.12 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Feb 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 169
Open 212.12
Bid (Size) 190.00 (100)
Ask (Size) 220.50 (100)
Prev. Close 212.12
Today's Range 212.12 - 212.12
52wk Range 125.38 - 256.36
Shares Outstanding 137,533,000
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Billionaire Stanley Druckenmiller Is Betting Big on These 2 Stocks ↗
February 21, 2026
These two stocks are core holdings in the legendary investor's portfolio. 
Via The Motley Fool
Topics Artificial Intelligence Earnings
News headline image
Natera to Report its Fourth Quarter and Full Year Results on February 26, 2026
February 17, 2026
From Natera, Inc.
Via Business Wire

Performance

YTD
-7.3%
-7.3%
1 Month
-12.2%
-12.2%
3 Month
-11.1%
-11.1%
6 Month
+30.6%
+30.6%
1 Year
+33.9%
+33.9%

More News

Read More
News headline image
Natera Launches EDEN Study on Early Risk Assessment for Preeclampsia and Adverse Pregnancy Outcomes
February 06, 2026
From Natera, Inc.
Via Business Wire
News headline image
Natera Submits Signatera™ CDx PMA to FDA
February 02, 2026
From Natera, Inc.
Via Business Wire
News headline image
Natera Announces Completion of Enrollment in Randomized ACES-EMB Trial in Heart Transplantation
January 28, 2026
From Natera, Inc.
Via Business Wire
News headline image
Prospera™ Featured in Landmark Interventional Study Advancing Lung Transplant Care
January 26, 2026
From Natera, Inc.
Via Business Wire
News headline image
2 Cash-Producing Stocks to Consider Right Now and 1 Facing Headwinds
January 25, 2026
Via StockStory
News headline image
Natera Publishes Clinical Validation of Latitude™ Tissue-Free MRD Test in Colorectal Cancer
January 21, 2026
From Natera, Inc.
Via Business Wire
News headline image
Natera’s Fetal Focus™ Single Gene NIPT (sgNIPT) Selected for Prestigious Oral Plenary Presentation at Society of Maternal Fetal Medicine (SMFM) Meeting
January 20, 2026
From Natera, Inc.
Via Business Wire
News headline image
GRAIL Surges as Canaccord Genuity Sets Ambitious $105 Price Target Following Robust 2025 Growth
January 13, 2026
Via MarketMinute
News headline image
Adaptive Biotechnologies Surges as Preliminary 2025 Results Signal a Turning Point in MRD Commercialization
January 13, 2026
Via MarketMinute
News headline image
Natera Announces Next Breakthrough in MRD-Based Risk Stratification, Leveraging Multi-Modal AI Modeling
January 13, 2026
From Natera, Inc.
Via Business Wire
News headline image
Natera to Scale AI Foundation Models in Precision Medicine with NVIDIA
January 12, 2026
From Natera, Inc.
Via Business Wire
News headline image
Natera Announces Strong Preliminary Fourth Quarter and 2025 Financial Results Driven by Record Signatera™ Growth
January 11, 2026
From Natera, Inc.
Via Business Wire
News headline image
2 Cash-Heavy Stocks to Keep an Eye On and 1 We Question
January 10, 2026
Via StockStory
Stay updated with the stocks that are on the move in today's after-hours session. ↗
January 07, 2026
Via Chartmill
News headline image
Exelixis and Natera to Collaborate on STELLAR-316, a Phase 3 Pivotal Trial of Zanzalintinib for Patients with Colorectal Cancer
January 07, 2026
From Exelixis, Inc.
Via Business Wire
News headline image
Natera Presents Updated Analyses From ALTAIR Clinical Trial at ASCO GI
January 05, 2026
From Natera, Inc.
Via Business Wire
News headline image
Natera Launches 21-Gene Fetal Focus™ Single-Gene NIPT, Powered By Ultra-Sensitive LinkedSNP™ Technology
January 05, 2026
From Natera, Inc.
Via Business Wire
News headline image
The Year-End Biotech Chill: Adaptive Biotechnologies Braces for J.P. Morgan Crucible Amid Market Sell-Off
December 30, 2025
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
3 Growth Stocks with Explosive Upside
December 28, 2025
Via StockStory
Topics Energy
News headline image
3 Reasons We’re Fans of Natera (NTRA)
December 23, 2025
Via StockStory
Topics Stocks
News headline image
3 Market-Beating Stocks Worth Your Attention
December 22, 2025
Via StockStory
News headline image
Natera to Participate in the 44th Annual J.P. Morgan Healthcare Conference
December 22, 2025
From Natera, Inc.
Via Business Wire
News headline image
Natera Announces Publication of Signatera™ Analysis from Randomized, Phase III CALGB (Alliance)/SWOG 80702 Study in Colorectal Cancer
December 18, 2025
From Natera, Inc.
Via Business Wire

Frequently Asked Questions

Is Natera, Inc. - Common Stock publicly traded?
Yes, Natera, Inc. - Common Stock is publicly traded.
What exchange does Natera, Inc. - Common Stock trade on?
Natera, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Natera, Inc. - Common Stock?
The ticker symbol for Natera, Inc. - Common Stock is NTRA on the Nasdaq Stock Market
What is the current price of Natera, Inc. - Common Stock?
The current price of Natera, Inc. - Common Stock is 212.12
When was Natera, Inc. - Common Stock last traded?
The last trade of Natera, Inc. - Common Stock was at 02/20/26 04:00 PM ET
What is the market capitalization of Natera, Inc. - Common Stock?
The market capitalization of Natera, Inc. - Common Stock is 29.17B
How many shares of Natera, Inc. - Common Stock are outstanding?
Natera, Inc. - Common Stock has 29B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap